XS
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.142
Exchange
XSTO - Nasdaq STOCKHOLM AB
—
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also XSpray Pharma
Company Analysis
XSPRAY.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
XSPRAY.ST financial analysis by Eyestock methodology
Valuation
XSPRAY.ST valuation using historical relative method
Statements
XSPRAY.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
XSPRAY.ST dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
XSpray Pharma`s Current ratio for the last twelve months ended 2023-12-31 is —
